4//SEC Filing
SCHLEIFER LEONARD S 4
Accession 0001883850-24-000025
CIK 0000872589other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 5:57 PM ET
Size
9.1 KB
Accession
0001883850-24-000025
Insider Transaction Report
Form 4
SCHLEIFER LEONARD S
DirectorCEO and President10% Owner
Transactions
- Sale
Common Stock
2024-05-17$979.22/sh−22,687$22,215,564→ 467,020 total - Sale
Common Stock
2024-05-17$980.07/sh−143$140,150→ 466,877 total
Holdings
- 5,932(indirect: By 401(k))
Common Stock
- 64,985(indirect: By Trust)
Common Stock
- 157,552(indirect: 2023 GRAT)
Common Stock
Footnotes (3)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- [F2]Represents volume-weighted average price of sales of 22,687 shares of Company stock on May 17, 2024 at prices ranging from $979.00 to $979.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 143 shares of Company stock on May 17, 2024 at prices ranging from $980.01 to $980.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001218629
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 5:57 PM ET
- Size
- 9.1 KB